Cargando…

ASCO 2018 highlights: metastatic breast cancer

This article reviews the clinically most relevant presentations at the American Society of Clinical Oncology (ASCO) annual meeting 2018 on the topic of metastatic breast cancer. In the randomized placebo-controlled phase 3 trial MONALEESA-3, testing ribociclib vs. placebo in combination with fulvest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Greil, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2018
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280779/ https://www.ncbi.nlm.nih.gov/pubmed/30595753 http://dx.doi.org/10.1007/s12254-018-0450-9

Ejemplares similares

SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Cure in metastatic breast cancer
por: Westphal, Theresa, et al.
Publicado: (2018)

CDK4/6 inhibition in luminal breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2016)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018)

Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options
por: Gampenrieder, Simon Peter, et al.
Publicado: (2020)

ASCO 2020: highlights in breast cancer
por: Bartsch, Rupert
Publicado: (2021)

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2019)

ASCO 2018 NSCLC highlights—combination therapy is key
por: Gamerith, Gabriele, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future
por: Gampenrieder, Simon P., et al.
Publicado: (2013)

ASCO 2017—highlights of gynecological cancer
por: Radl, Bianca, et al.
Publicado: (2017)

ASCO-update: gastrointestinal tumors
por: Weiss, Lukas, et al.
Publicado: (2017)

ASCO 2016: highlights in breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2016)

ASCO 2017: highlights in breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2017)

ASCO Congress 2018: melanoma treatment
por: Richtig, Erika
Publicado: (2018)

ASCO 2020 non-small lung cancer (NSCLC) personal highlights
por: Horvath, Lena, et al.
Publicado: (2021)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
por: Magnes, Teresa, et al.
Publicado: (2017)

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2018)

Highlights in breast cancer from ASCO 2016
por: Cardoso, Fatima
Publicado: (2016)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Highlights of ASCO 2023
por: Neugut, Alfred I, et al.
Publicado: (2023)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
por: Rinnerthaler, Gabriel, et al.
Publicado: (2016)

ASCO highlights podcast: head and neck cancers
por: Merlano, Marco
Publicado: (2016)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer
Publicado: (2019)

Breast Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Breast Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2022)

2017 ASCO Highlights on Gastointestinal Malignancies
por: Paluri, Ravi Kumar
Publicado: (2017)

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2022)

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
por: Huemer, Florian, et al.
Publicado: (2018)

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)
por: Rinnerthaler, Gabriel, et al.
Publicado: (2021)

Genitourinary cancers updates: highlights from ASCO 2023
por: Qin, Qian, et al.
Publicado: (2023)

Breast Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Publicado: (2020)

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
por: Rinnerthaler, Gabriel, et al.
Publicado: (2020)

ASCO 2016 – update colorectal liver metastases
por: Kaczirek, Klaus
Publicado: (2017)

Adjuvant medical treatment for breast cancer in elderly and old women
por: Westphal, Theresa, et al.
Publicado: (2016)

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
por: Gampenrieder, Simon Peter, et al.
Publicado: (2021)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7pcun2h46pt4t1hvma2j2nva5h